| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Acute Promyelocytic Leukemia
|
Yanada, Masamitsu
|
|
|
|
12 |
p. 847.e1-847.e8
|
artikel
|
| 2 |
Allogeneic Hematopoietic Cell Transplantation from Alternative Donors in Acute Myelogenous Leukemia: A Comparative Analysis
|
Yanada, Masamitsu
|
|
|
|
12 |
p. 1005.e1-1005.e8
|
artikel
|
| 3 |
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population
|
Wedge, Eileen
|
|
|
|
12 |
p. 991.e1-991.e9
|
artikel
|
| 4 |
Allogeneic Transplantation for Older Patients with Acute Myeloid Leukemia: The Dawn of a New Era
|
Lin, Richard J.
|
|
|
|
12 |
p. 793-794
|
artikel
|
| 5 |
Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults
|
Chee, Lynette
|
|
|
|
12 |
p. 953-954
|
artikel
|
| 6 |
American Society for Transplantation and Cellular Therapy Return to Work Guidance Committee Recommendations for Health Care Providers Who Take Care of Hematopoietic Cell Transplantation Patients
|
Salit, Rachel B.
|
|
|
|
12 |
p. 822-828
|
artikel
|
| 7 |
American Society for Transplantation and Cellular Therapy Series: #4 - Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation
|
Yong, Michelle K.
|
|
|
|
12 |
p. 957-967
|
artikel
|
| 8 |
American Society of Transplantation and Cellular Therapy Series: #7 - Management of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients
|
El Chaer, Firas
|
|
|
|
12 |
p. 730-738
|
artikel
|
| 9 |
A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation
|
Grosso, Dolores
|
|
|
|
12 |
p. 831.e1-831.e7
|
artikel
|
| 10 |
A Reflection Inspired by Reflections
|
Martin, Paul J.
|
|
|
|
12 |
p. 723-724
|
artikel
|
| 11 |
ASTCT Notes
|
|
|
|
|
12 |
p. 1024
|
artikel
|
| 12 |
ASTCT Notes
|
|
|
|
|
12 |
p. 861
|
artikel
|
| 13 |
Bacterial Bloodstream Infections in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
|
Salas, María Queralt
|
|
|
|
12 |
p. 850.e1-850.e10
|
artikel
|
| 14 |
Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
|
Mehta, Rohtesh S.
|
|
|
|
12 |
p. 1003.e1-1003.e13
|
artikel
|
| 15 |
Comparison of Dose Adjustment Strategies for Obesity in High-dose Cyclophosphamide Among Adult Hematopoietic Cell Transplantation Recipients: Pharmacokinetic Analysis
|
Takahashi, Takuto
|
|
|
|
12 |
p. 845.e1-845.e8
|
artikel
|
| 16 |
Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia
|
Onishi, Yasushi
|
|
|
|
12 |
p. 766.e1-766.e8
|
artikel
|
| 17 |
Consolidative Autotransplantation Achieves High Cure Rates in Adverse-Risk Large B Cell Lymphoma
|
Puckrin, Robert
|
|
|
|
12 |
p. 763.e1-763.e5
|
artikel
|
| 18 |
Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter Trial
|
Slade, Michael
|
|
|
|
12 |
p. 764.e1-764.e7
|
artikel
|
| 19 |
Distress in a Pandemic: Association of the Coronavirus Disease-2019 Pandemic with Distress and Quality of Life in Hematopoietic Stem Cell Transplantation
|
Amonoo, Hermioni L.
|
|
|
|
12 |
p. 1015.e1-1015.e7
|
artikel
|
| 20 |
Editorial Board
|
|
|
|
|
12 |
p. A6
|
artikel
|
| 21 |
Editorial Board
|
|
|
|
|
12 |
p. A10
|
artikel
|
| 22 |
Editorial Board
|
|
|
|
|
12 |
p. A2
|
artikel
|
| 23 |
Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease
|
Zewde, Makda Getachew
|
|
|
|
12 |
p. 988.e1-988.e7
|
artikel
|
| 24 |
Feasibility and Implementation of a Multimodal Supportive Care Program to Improve Outcomes in Older Patients Undergoing Allogeneic Stem Cell Transplantation
|
Szewczyk, Nicholas A.
|
|
|
|
12 |
p. 1008-1014
|
artikel
|
| 25 |
Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic
|
Purtill, Duncan
|
|
|
|
12 |
p. 1022.e1-1022.e6
|
artikel
|
| 26 |
Graft-Versus-Host Disease Prophylaxis Using Low-Dose Antithymocyte Globulin in Peripheral Blood Stem Cell Transplantation—A Matched-Pair Analysis
|
Shiratori, Souichi
|
|
|
|
12 |
p. 995.e1-995.e6
|
artikel
|
| 27 |
Guidelines for Pediatric Unrelated Cord Blood Transplantation—Unique Considerations
|
Dahlberg, Ann
|
|
|
|
12 |
p. 968-972
|
artikel
|
| 28 |
Haploidentical Allogeneic Stem Cell Transplantation in Sickle Cell Disease: A Systematic Review and Meta-Analysis
|
Aydin, Mesire
|
|
|
|
12 |
p. 1004.e1-1004.e8
|
artikel
|
| 29 |
Haploidentical Cord Blood Transplantation with 8 mg/kg Antithymocyte Globulin as Graft-versus-Host Disease Prophylaxis Compared to Haploidentical Transplantation with 10 mg/kg Antithymocyte Globulin in the Treatment of Acute Leukemia
|
Yuan, Fangfang
|
|
|
|
12 |
p. 771.e1-771.e10
|
artikel
|
| 30 |
Haplo-Peripheral Blood Stem Cell Plus Cord Blood Grafts for Hematologic Malignancies Might Lead to Lower Relapse Compared with Haplo-Peripheral Blood Stem Cell Plus Bone Marrow Grafts
|
Huang, Fen
|
|
|
|
12 |
p. 849.e1-849.e8
|
artikel
|
| 31 |
Hospitalization and Healthcare Resource Utilization of Omidubicel-Onlv versus Umbilical Cord Blood Transplantation for Hematologic Malignancies: Secondary Analysis from a Pivotal Phase 3 Clinical Trial
|
Majhail, Navneet S.
|
|
|
|
12 |
p. 749.e1-749.e5
|
artikel
|
| 32 |
Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation–A Systematic Review and Meta-Analysis
|
Bewersdorf, Jan Philipp
|
|
|
|
12 |
p. 997.e1-997.e11
|
artikel
|
| 33 |
Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience
|
Chin, Kuo-Kai
|
|
|
|
12 |
p. 990.e1-990.e7
|
artikel
|
| 34 |
Impact of Cytomegalovirus Replication in Patients with Aggressive B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy
|
Márquez-Algaba, Ester
|
|
|
|
12 |
p. 851.e1-851.e8
|
artikel
|
| 35 |
Impact of in Vivo Lymphodepletion on Outcome in Children with Nonmalignant Disorders Receiving Peripheral Blood Stem Cell Transplantation
|
Ottaviano, Giorgio
|
|
|
|
12 |
p. 1020.e1-1020.e5
|
artikel
|
| 36 |
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH Study
|
Bastos-Oreiro, Mariana
|
|
|
|
12 |
p. 747.e1-747.e10
|
artikel
|
| 37 |
Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades
|
Ohbiki, Marie
|
|
|
|
12 |
p. 768.e1-768.e10
|
artikel
|
| 38 |
Incidence and Outcome of Atypical Manifestations of Chronic Graft-versus-Host Disease: Results From a Retrospective Single-Center Analysis
|
Doering, Jana
|
|
|
|
12 |
p. 772.e1-772.e10
|
artikel
|
| 39 |
Increased Incidence of Human Papillomavirus-Related Precancer or Second Malignancy Among Allogeneic Stem Cell Transplantation Patients: A SEER-Medicare Population Study
|
Zhao, Hui
|
|
|
|
12 |
p. 1016.e1-1016.e9
|
artikel
|
| 40 |
Increased Rates of Rhabdomyolysis in Male Hematopoietic Cell Transplantation Recipients Taking Sirolimus and Trimethoprim/Sulfamethoxazole
|
Lew, Jeffrey
|
|
|
|
12 |
p. 1019.e1-1019.e4
|
artikel
|
| 41 |
Integration of Daily Patient-Reported Outcome Measures in Pediatric Stem Cell Transplantation
|
Hetzer, Benjamin
|
|
|
|
12 |
p. 776.e1-776.e7
|
artikel
|
| 42 |
Is Haploidentical Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide Feasible in Sub-Saharan Africa?
|
du Toit, Justin Rudolph
|
|
|
|
12 |
p. 1002.e1-1002.e8
|
artikel
|
| 43 |
Late Effects of Severe Acute Graft-versus-Host Disease on Quality of Life, Medical Comorbidities, and Survival
|
Rashid, Nahid
|
|
|
|
12 |
p. 844.e1-844.e8
|
artikel
|
| 44 |
Limited Contribution of Donor Characteristics to One-Year Survival After Hematopoietic Stem Cell Transplantation
|
Israeli, Sapir
|
|
|
|
12 |
p. 843.e1-843.e6
|
artikel
|
| 45 |
Linking the Center for International Blood and Marrow Transplant Research Registry to the California Cancer Registry and California Hospital Patient Discharge Data
|
Keegan, Theresa H.M.
|
|
|
|
12 |
p. 859.e1-859.e10
|
artikel
|
| 46 |
Long-Term Cryopreservation of Peripheral Blood Stem Cell Harvest Using Low Concentration (4.35%) Dimethyl Sulfoxide with Methyl Cellulose and Uncontrolled Rate Freezing at -80 °C: An Effective Option in Resource-Limited Settings
|
Gokarn, Anant
|
|
|
|
12 |
p. 777.e1-777.e8
|
artikel
|
| 47 |
Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia
|
Beelen, Dietrich W.
|
|
|
|
12 |
p. 834-842
|
artikel
|
| 48 |
Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation Analysis
|
Derigs, Patrick
|
|
|
|
12 |
p. 750-756
|
artikel
|
| 49 |
Long-term Survivors and Failures of CAR-T Therapy for Lymphoma: Is there a Role for Allogeneic Transplantation After the CAR-T Crash?
|
Spinner, Michael A.
|
|
|
|
12 |
p. 725-726
|
artikel
|
| 50 |
Lower Incidence of Cytomegalovirus Reactivation Following Post-Transplantation Cyclophosphamide HLA-Mismatched Unrelated Donor Transplantation
|
Camargo, Jose F
|
|
|
|
12 |
p. 1017.e1-1017.e7
|
artikel
|
| 51 |
Low Rates of Cerebral Infarction after Hematopoietic Stem Cell Transplantation in Patients with Sickle Cell Disease at High Risk for Stroke
|
Carpenter, Jessica L.
|
|
|
|
12 |
p. 1018.e1-1018.e9
|
artikel
|
| 52 |
Masthead (Purpose and Scope)
|
|
|
|
|
12 |
p. A5
|
artikel
|
| 53 |
Masthead (Purpose and Scope)
|
|
|
|
|
12 |
p. A9
|
artikel
|
| 54 |
Masthead (Purpose and Scope)
|
|
|
|
|
12 |
p. A1
|
artikel
|
| 55 |
Nomenclature for Cellular and Genetic Therapies: A Need for Standardization
|
Sharma, Akshay
|
|
|
|
12 |
p. 795-801
|
artikel
|
| 56 |
Ocular Chronic Graft-versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes after Allogeneic Hematopoietic Cell Transplantation
|
Jeppesen, Helene
|
|
|
|
12 |
p. 833.e1-833.e7
|
artikel
|
| 57 |
Officers and Directors of ASTCT
|
|
|
|
|
12 |
p. A7
|
artikel
|
| 58 |
Officers and Directors of ASTCT
|
|
|
|
|
12 |
p. A11
|
artikel
|
| 59 |
Officers and Directors of ASTCT
|
|
|
|
|
12 |
p. A4
|
artikel
|
| 60 |
Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple Myeloma
|
Pasvolsky, Oren
|
|
|
|
12 |
p. 757-762
|
artikel
|
| 61 |
Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Patients with Reduced Renal Function Including Dialysis
|
Wood, Anthony C.
|
|
|
|
12 |
p. 829.e1-829.e8
|
artikel
|
| 62 |
Pilot Trial of Homebound Hematopoietic Cell Transplantation
|
Landau, Heather J.
|
|
|
|
12 |
p. 832.e1-832.e7
|
artikel
|
| 63 |
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy
|
Orfali, Nina
|
|
|
|
12 |
p. 993.e1-993.e8
|
artikel
|
| 64 |
Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
|
Sahebi, Firoozeh
|
|
|
|
12 |
p. 999.e1-999.e10
|
artikel
|
| 65 |
Predicting Patient Death after Allogeneic Stem Cell Transplantation for Inborn Errors Using Machine Learning (PREPAD): A European Society for Blood and Marrow Transplantation Inborn Errors Working Party Study
|
von Asmuth, Erik G.J.
|
|
|
|
12 |
p. 775.e1-775.e8
|
artikel
|
| 66 |
Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop
|
Auletta, Jeffery J.
|
|
|
|
12 |
p. 739-746
|
artikel
|
| 67 |
Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHD
|
Novitzky-Basso, Igor
|
|
|
|
12 |
p. 773.e1-773.e10
|
artikel
|
| 68 |
Real-World Experience in Extracorporeal Photopheresis for Adults with Graft-versus-Host Disease
|
Asensi Cantó, Pedro
|
|
|
|
12 |
p. 765.e1-765.e8
|
artikel
|
| 69 |
Relationship Between Pretransplantation Nutritional Status and Outcome in Adults with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
|
Orvain, Corentin
|
|
|
|
12 |
p. 846.e1-846.e9
|
artikel
|
| 70 |
Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)
|
Dioverti, Veronica
|
|
|
|
12 |
p. 810-821
|
artikel
|
| 71 |
Risk of Subsequent Malignant Neoplasms Following Hematopoietic Stem Cell Transplantation with Total Body Irradiation or Total Marrow Irradiation: Insights from Early Follow-Up
|
Ladbury, Colton
|
|
|
|
12 |
p. 860.e1-860.e6
|
artikel
|
| 72 |
Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia
|
Tschernia, Nicholas P.
|
|
|
|
12 |
p. 1021.e1-1021.e5
|
artikel
|
| 73 |
Severity of Acute Graft-versus-Host Disease and Associated Healthcare Resource Utilization, Cost, and Outcomes
|
Farhadfar, Nosha
|
|
|
|
12 |
p. 1007.e1-1007.e8
|
artikel
|
| 74 |
Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation
|
Patel, Pratik A.
|
|
|
|
12 |
p. 778.e1-778.e6
|
artikel
|
| 75 |
State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses
|
Meir, Juliet
|
|
|
|
12 |
p. 973-987
|
artikel
|
| 76 |
Survivors of Pediatric Hematopoietic Stem Cell Transplantation Exhibit Progressive Diastolic Dysfunction Over Years of Follow-Up
|
Harrison, David J.
|
|
|
|
12 |
p. 774.e1-774.e8
|
artikel
|
| 77 |
Table of Contents
|
|
|
|
|
12 |
p. A13-A17
|
artikel
|
| 78 |
Table of Contents
|
|
|
|
|
12 |
p. A17-A20
|
artikel
|
| 79 |
Table of Contents
|
|
|
|
|
12 |
p. A5-A8
|
artikel
|
| 80 |
The ASTCT-NMDP ACCESS Initiative: A Collaboration to Address and Sustain Equal Outcomes for All across the Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem
|
Auletta, Jeffery J.
|
|
|
|
12 |
p. 802-809
|
artikel
|
| 81 |
The Role of Autologous Stem Cell Transplant in Ultra-High-Risk Myeloma: Do the Ends Still Justify the Means?
|
Paul, Barry
|
|
|
|
12 |
p. 727-729
|
artikel
|
| 82 |
To Transplant or Not To Transplant in First Remission Acute Lymphoblastic Leukemia? Study group data give some answers, but not all
|
Spyridonidis, Alexandros
|
|
|
|
12 |
p. 791-792
|
artikel
|
| 83 |
Transplantation for Older Adults-More Questions than Answers
|
McCurdy, Shannon R.
|
|
|
|
12 |
p. 955-956
|
artikel
|
| 84 |
Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative Conditioning
|
Joseph, Jacinth
|
|
|
|
12 |
p. 770.e1-770.e6
|
artikel
|
| 85 |
Trends in Allogeneic Hematopoietic Cell Transplantation Utilization and Estimated Unmet Need Among Medicare Beneficiaries with Acute Myelogenous Leukemia
|
Mau, Lih-Wen
|
|
|
|
12 |
p. 852-858
|
artikel
|
| 86 |
Ultra-High Dose Vitamin D in Pediatric Hematopoietic Stem Cell Transplantation: A Nonrandomized Controlled Trial
|
Bhandari, Rusha
|
|
|
|
12 |
p. 1001.e1-1001.e9
|
artikel
|
| 87 |
Von Willebrand Factor and Platelet Levels before Conditioning Chemotherapy Indicate Bone Marrow Regeneration following Autologous Hematopoietic Stem Cell Transplantation
|
Radnay, Zita
|
|
|
|
12 |
p. 830.e1-830.e7
|
artikel
|
Tijdschrift beschrijving